Compare NRSN & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRSN | FMST |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | Israel | Canada |
| Employees | 16 | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 30.5M |
| IPO Year | N/A | N/A |
| Metric | NRSN | FMST |
|---|---|---|
| Price | $0.70 | $1.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 131.3K | 82.7K |
| Earning Date | 03-31-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $583.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1.41 |
| 52 Week High | $2.52 | $4.57 |
| Indicator | NRSN | FMST |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | 44.61 |
| Support Level | $0.67 | $1.49 |
| Resistance Level | $0.75 | $1.94 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 11.50 | 26.36 |
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.